Skip to main content
SpringerLink
Log in

Including Traditional Chinese Medicine Diagnoses in ICD-11 May Not Advance the Evaluation of Traditional Chinese Medicine Therapies

  • Commentary
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

The Original Article was published on 26 July 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gorski D. ICD-11: a triumph of the “integration” of quackery with real medicine. Science-Based Medicine; 2018. https://sciencebasedmedicine.org/icd-11-a-triumph-of-the-integration-of-quackery-with-real-medicine/. Accessed 3 Aug 2019.

  2. Singh RH, Rastogi S. WHO ICD-11 showcasing of traditional medicine: lesson from a lost opportunity. Ann Ayurvedic Med. 2018;7(3–4):66–71.

    Google Scholar 

  3. World Health Organization. International Classification of Diseases (ICD) information sheet. https://www.who.int/classifications/icd/factsheet/en/. Accessed 3 Aug 2019.

  4. Lu W, Dean-Clower E, Doherty-Gilman A, Rosenthal DS. The value of acupuncture in cancer care. Hematol Oncol Clin N Am. 2008;22(4):631–48.

    Article  Google Scholar 

  5. Johnson L. ICD-11: hurry up and wait. ICD10 Monitor. https://www.icd10monitor.com/icd-11-hurry-up-and-wait. Accessed 3 Aug 2019.

  6. Liu SH, Chuang WC, Lam W, Jiang Z, Cheng YC. Safety surveillance of traditional Chinese medicine: current and future. Drug Saf. 2015;38(2):117–28.

    Article  Google Scholar 

  7. Xiao X, Tang J, Mao Y, et al. Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injury. Issued by China Food and Drug Administration. Acta Pharm Sin B. 2019;9(3):648–58.

    Article  Google Scholar 

  8. Lam WC, Lyi A, Bian Z. ICD-11: impact on traditional Chinese medicine and world healthcare systems. Pharm Med. 2019;33(5):1–5. https://doi.org/10.1007/s40290-019-00295-y (page numbers to be added at issue build).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eisai Co., Ltd., Koishikawa 4-6-10, Bunkyo-ku, Tokyo, 112-8088, Japan

    Stewart Geary

Authors
  1. Stewart Geary
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stewart Geary.

Ethics declarations

Funding

No sources of funding were used to support the writing of this commentary.

Conflict of interest

Stewart Geary is an employee of Eisai Co., Ltd but has no financial interest for or against Traditional Chinese Medicine.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Geary, S. Including Traditional Chinese Medicine Diagnoses in ICD-11 May Not Advance the Evaluation of Traditional Chinese Medicine Therapies. Pharm Med 33, 369–371 (2019). https://doi.org/10.1007/s40290-019-00297-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40290-019-00297-w

Search

Navigation